A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. For American men, prostate cancer is the most common cancer ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback